NCT00457483View on ClinicalTrials.gov

Nijmegen Antihypertensive Management Improvement Study

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

March 31, 2011

Conditions
Primary Hypertension
Interventions
DRUG

hydrochlorothiazide

12.5 mg once-a-day

DRUG

valsartan, 80 mg once-a-day

80 mg once-a-day

Trial Locations (1)

Unknown

Nijmegen monitoring project coordinated from Nijmegen, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT00457483 - Nijmegen Antihypertensive Management Improvement Study | Biotech Hunter | Biotech Hunter